Earnings4569KYORIN Pharmaceutical Co.,Ltd.
Kyorin Pharmaceutical Reports Q1 Revenue of 29.7 billion, Down 2%
TOKYO, Jul 30 (Pulse News Wire) – Kyorin Pharmaceutical Co., Ltd. (4569.T) reported consolidated results for Q1 FY2027 (ending March 2027).
Revenue was ¥29.7 billion (-1.9% YoY). operating profit was ¥964 million (-59.3%). net profit attributable to shareholders was ¥824 million (-60.8%).
Total assets stood at ¥190 billion with an equity ratio of 74.4%. The company declared an annual dividend of ¥15 per share. The full-year forecast for the current fiscal year is revenue of ¥120 billion (-3.5%).
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥29,654M | -1.9% |
| Operating profit | ¥964M | -59.3% |
| Net profit | ¥824M | -60.8% |
Next period forecast
Revenue
¥121,800M
-3.5%Op. profit
¥2,000M
-43.9%Net profit
¥1,500M
-56.5%Source: TDNet filing · Figures in millions of yen
End of article